MEL13 Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Crowdfunding
- Latest Deal Amount
-
$1.39M
- Investors
-
2
MEL13 General Information
Description
Developer of melatonin skin ointments designed to regenerate aging skin and for treatment of skin diseases. The company engages in research of melatonin and cell aging formulations to produce ointments and intensive serums that are used for nourishing, moisturizing, and cellular repairing of multiple skin types such as normal, mixed, and oily, enabling customers to reduce wrinkles, restore firmness, and retain healthy skin
Contact Information
Website
www.mel13.comCorporate Office
- C. Ángel Ganivet, 6
- Office 20-21
- 18009 Granada
- Spain
Corporate Office
- C. Ángel Ganivet, 6
- Office 20-21
- 18009 Granada
- Spain
MEL13 Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Equity Crowdfunding | 30-Aug-2023 | $1.39M | Completed | Generating Revenue | ||
| 3. Later Stage VC | 31-Dec-2019 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 12-Sep-2016 | $241K | $241K | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2014 | Completed | Startup |
MEL13 Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
MEL13 Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MEL13 Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MEL13 Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 1nkemia | Holding Company | Minority | ||
| University of Granada | University |
MEL13 FAQs
-
When was MEL13 founded?
MEL13 was founded in 2014.
-
Where is MEL13 headquartered?
MEL13 is headquartered in Granada, Spain.
-
What is the size of MEL13?
MEL13 has 12 total employees.
-
What industry is MEL13 in?
MEL13’s primary industry is Personal Products.
-
Is MEL13 a private or public company?
MEL13 is a Private company.
-
What is the current valuation of MEL13?
The current valuation of MEL13 is .
-
What is MEL13’s current revenue?
The current revenue for MEL13 is .
-
How much funding has MEL13 raised over time?
MEL13 has raised $2.19M.
-
Who are MEL13’s investors?
1nkemia and University of Granada have invested in MEL13.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
